ChengDa Pharmaceuticals Co. Ltd. (301201) — Free Cash Flow Generation Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Free Cash Flow Generation Index of -1.03x as of December 2025. Free cash flow of CN¥-35.00 Million represents -1% of operating cash flow (CN¥34.02 Million). Explore reinvestment intensity of ChengDa Pharmaceuticals Co. Ltd. to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ChengDa Pharmaceuticals Co. Ltd. Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for ChengDa Pharmaceuticals Co. Ltd. across 7 annual periods. For the full cash flow conversion analysis, see 301201 cash flow metrics.
Annual Free Cash Flow Generation for ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Year-by-year Free Cash Flow Generation Index for ChengDa Pharmaceuticals Co. Ltd.. Check 301201 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.03x | CN¥-35.00 Million | CN¥34.02 Million | CN¥69.02 Million | ▲ +88.6% |
| 2024 | -9.00x | CN¥-257.72 Million | CN¥28.65 Million | CN¥286.36 Million | ▼ -5200.6% |
| 2023 | -0.17x | CN¥-32.60 Million | CN¥192.07 Million | CN¥224.67 Million | ▲ +94.9% |
| 2022 | -3.32x | CN¥-158.03 Million | CN¥47.67 Million | CN¥205.69 Million | ▼ -396.1% |
| 2021 | -0.67x | CN¥-55.56 Million | CN¥83.14 Million | CN¥138.70 Million | ▼ -232.3% |
| 2020 | 0.51x | CN¥65.16 Million | CN¥128.97 Million | CN¥63.81 Million | ▲ +107.2% |
| 2019 | 0.24x | CN¥16.46 Million | CN¥67.52 Million | CN¥51.06 Million | — |